Treatment of Chronic Myofascial Pain with Botulinum Toxin : Case Report |
Hong, Seong-Ju
(Department of Oral medicine, School of Dentistry, Chosun University)
Yoon, Chang-Lyuk (Department of Oral medicine, School of Dentistry, Chosun University) Ahn, Jong-Mo (Department of Oral medicine, School of Dentistry, Chosun University) Ryu, Ji-Won (Department of Oral medicine, School of Dentistry, Chosun University) |
1 | Sharav Y, Singer E, Schmidt E, et al.: The analgesic effect of amitriptyline on severe facial pain. Pain 1987;31:199-203. DOI ScienceOn |
2 | Qerama E, Fuglsang-Frederiksen A, Jensen TS. The role of botulinum toxin in management of pain: an evidence-based review. Curr Opin Anaesthesiol 2010; 23(5):602-610. DOI ScienceOn |
3 | Hong CZ, Simons DG. Pathophysiologic and electrophysiologic mechanism of myofascial trigger points. Arch Phys Med Rehabil 1998;79:863-872. DOI ScienceOn |
4 | Svensson P, List T, Hector G. Analysis of stimulusevoked pain in patients with myofascial temporomandibular pain disorders. Pain 2001;92:399-409. DOI ScienceOn |
5 | Fricton JR, Kroening R, Haley D, Siegert R. Myofascial pain syndrome of the head and neck: a review of clinical characteristics of 164 patients. Oral Surg Oral Med Oral Pathol 1985;60:615-623. DOI ScienceOn |
6 | Aoki KR. Review of a proposed mechanisms for the antinociceptive action of botulinum toxin type A. NeuroToxicology 2005;26:785 - 793. DOI ScienceOn |
7 | Filippi GM, Errico P, Santarelli R, Bagolini B, Manni E. Botulinum A toxin effects on rat jawmuscle spindles. Acta Otolaryngol 1993;113:400 - 404. DOI ScienceOn |
8 | Babcock MS, Foster L, Pasquina P, Jabbari B. Treatment of pain attributed to plantar fasciitis with Botulinum toxin A: A short-term, randomized, placebo-controlled, double-blind study. Am J Phys Med Rehabil 2005;84:649 - 654. DOI ScienceOn |
9 | Tarsy D, First ER. Painful cervical dystonia: clinical features and response to treatment with botulinum toxin. Mov Disord 1999;14:1043 - 1045. DOI ScienceOn |
10 | Brin MF, Fahn S, Moskowitz C, et al. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Adv Neurol 1988;50:599 - 608. |
11 | Kerr FW. A mechanism to account for frontal headache in cases of posterior fosse tumors. J Neurosurg 1961;18:605-609. DOI |
12 | Al-Ani Z, Gray RJ, Davies SJ, Sloan P, Glenny AM. Stabilization splint therapy for the treatment of temporomandibular myofascial pain: a systematic review. J Dent Educ 2005;69(11):1242-1250. |
13 | Piovesan EJ, Werneck LC, Teive HA, et al. Neurophysiology of pain in tentorial irritation: description of a case secondary to medulloblastoma. Arq Neuropsiquiatr 1998;56:677-682. DOI ScienceOn |
14 | utchinson PJ, Pickard JD, Higgins JN: Vertebral artery dissection presenting as cerebellar infarction. J Neurol Neurosurg Psychiatry 2000;68:98-99. DOI ScienceOn |
15 | Tsuga K, Akagawa Y, Sakaguchi R, Tsuru H. A short-term evaluation of the effectiviness of stabilisation therapy for specific symptoms of temporomandibular joint dysfunction syndrome. J Prosthet Dent 1989;61:610-613. DOI ScienceOn |
16 | Gray RJM, Davies SJ, Quale AA. A comparison of two splints in the treatment of TMJ myofascial pain: can occlusal analysis be used to predict success of splint therapy? Br Dent J 1991;170:257-261. DOI ScienceOn |
17 | Davies SJ, Gray RJM. The pattern of splint usage in the management of two common temporomandibular disorders. Part III: Long-term follow-up in an assessment of splint therapy in the management of disc displacement with reduction and pain dysfunction syndrome. Br Dent J 1997;183:279-283. DOI ScienceOn |
18 | Fricton JR, Kroening R, Haley D, Siegert R. Myofascial pain syndrome of the head and neck: a review of clinical characteristics of 164 patients. Oral Surg Oral Med Oral Pathol 1985;60:615 - 623. DOI ScienceOn |
19 | Graff-Radford SB. Regional myofascial pain syndrome and headache: principles of diagnosis and management. Curr Pain Headache Rep 2001;5(4): 376-381. DOI ScienceOn |
20 | Majlesi J, Unalan H. Effect of treatment on trigger points. Curr Pain Headache Rep 2010;14(5):353-360. DOI ScienceOn |
21 | Travell JG, Simons DG. Myofascial Pain and Dysfunction: The Trigger Point Manual. Baltimore, 1983, Williams and Wilkins, pp 24-25. |
22 | Graff-Radford SB. Myofascial pain: diagnosis and management. Curr Pain Headache Rep 2004;8: 463-467. DOI ScienceOn |
23 | Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research group. Headache 2000;40:445 - 450. DOI ScienceOn |
24 | Foster L, Clapp L, Erickson M, Jabbari B. Botulinum toxin A and chronic low back pain. Neurology 2001;56:1290 - 1293. DOI ScienceOn |
25 | Steinder A. The interpretation of the sciatic radiation and the syndrome of low back pain. J Bone Joint Surg 1940;22:28-34. |
26 | Rand J, Whaler BC. Impairment of sympathetic transmission by Botulinum toxin. Nature 1965;206:588 - 591. DOI ScienceOn |
27 | Han SC, Harrison P. Myofascial pain syndrome and triggerpoint management. Reg Anesth 1997;22:89-101. DOI ScienceOn |
28 | Stohler CS. Masticatory myalgias. In Oral and Maxillofacial Surgery. Temporomandibular Disorders. Philadelphia, 2000, WB Saunders, pp.38 - 45. |
29 | Piovesan EJ, Werneck LC, Teive HA, et al. Neurophysiology of pain in tentorial irritation: description of a case secondary to medulloblastoma. Arq Neuropsiquiatr 1998;56:677-682. DOI ScienceOn |
30 | Fricton JR. Myofascial pain: clinical characteristics and diagnostic criteria. J Musculoskel Pain 1993;1: 37-47. |
31 | Simons DG, Travell JG, Simons LS. Travell & Simons's Myofascial Pain and Dysfunction: The Trigger Point Manual. 2nd edi., Baltimore, 1999,Williams & Wilkins, pp. 11-86. |
32 | Fleckenstein J, Zaps D, Ruger LJ, et al. Discrepency between prevalence and perceived effectiveness of treatment methods in myofascial pain syndrome: Results of a cross-sectional, nationwide survey. BMC Musculoskelet Disord 2010;11:32-41. DOI ScienceOn |
33 | Piovesan EJ, Kowacs PA, Oshinsky ML. Convergence of cervical and trigeminal sensory afferents. Curr Pain Headache Rep 2003;7(5):377-83. DOI ScienceOn |
34 | Jankovic J, Tintner R. Botulinum toxin for the treatment of cervical dystonia. Expert Opinion 2001;2:1985 - 1994. DOI ScienceOn |
35 | Abbott JA, Jarvis SK, Lyons SD, Thompson A, Vancaille TG. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: A randomized controlled trial. Obstet Gynecol 2006;108:915 - 923. DOI ScienceOn |
36 | Hutchinson PJ, Pickard JD, Higgins JN. Vertebral artery dissection presenting as cerebellar infarction. J Neurol Neurosurg Psychiatry 2000;68:98–99. DOI ScienceOn |